Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Asprosın And Tumor Necrosıs Factor-α Levels In Type 2 Dıabetıc Chronıc Periodontitis
A completed clinical trial evaluating aspirin's effect on tumor necrosis factor-α levels in people with type 2 diabetes and chronic periodon…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Effect of Inhalational Anesthesia Versus Total Intravenous Anesthesia on Blood Glucose in Type 2 Diabetes Patients [NA]
A clinical trial compares inhalational anesthesia versus total intravenous anesthesia and monitors blood glucose in patients with Type 2 Dia…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes [Phase 1]
Phase 1 pharmacokinetic/pharmacodynamic study of bardoxolone methyl in patients with chronic kidney disease and type 2 diabetes has been ter…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL) [Phase 4]
RADIAL is a Phase 4 trial evaluating remote and decentralized approaches to clinical trials for Type 2 diabetes mellitus; the study status i…
-
FDA approval · 2025-05-28FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for XULTOPHY 100/3.6 (insulin degludec and liraglutide) from Novo Nordisk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-05-28FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Trulicity (dulaglutide) from Eli Lilly and Company. This action completes regulatory approva…
-
FDA approval · 2025-05-28FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for SOLIQUA 100/33 (insulin glargine and lixisenatide) from Sanofi-Aventis U.S. LLC.
-
FDA label_change · 2025-05-28FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA entry documents a supplemental application for BYETTA (exenatide) submitted by AstraZeneca.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression
A clinical trial is investigating whether berberine can improve type 2 diabetes mellitus complicated by depression by exploring its molecula…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Utilization Study and Evaluation of Educational Intervention on HbA1c Testing [NA]
This University of British Columbia clinical trial assesses utilization of HbA1c testing and an educational intervention for quality improve…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Emulation of the SOUL Diabetes Trial in Healthcare Claims
Brigham and Women's Hospital reports a completed study that emulates the SOUL Diabetes Trial using healthcare claims data.
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study [Phase 2]
A Phase 2 clinical trial (FibroCAN) is evaluating finerenone for diabetic cardiovascular autonomic neuropathy and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes [Phase 3]
A Phase 3 trial evaluating cilostazol plus Ginkgo biloba to improve cognitive function in elderly patients with type 2 diabetes is currently…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Enhancing Diabetes Care: Exposome &Amp; Sensors
This clinical trial update notes a University of Illinois at Chicago study investigating how exposome data and wearable sensors can enhance …
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
A completed clinical trial update describes emulating the PIONEER6 trial for Type 2 diabetes using healthcare claims data to assess outcomes…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial is evaluating pioglitazone plus empagliflozin for fatty liver disease in people with type 2 diabetes and is current…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Precision Diets for Diabetes Prevention [NA]
Stanford University is conducting a clinical trial on precision diet strategies to prevent diabetes in individuals with prediabetes and insu…
-
EMA approval · 2025-05-23EMA Authorised: Komboglyze (metformin hydrochloride;saxagliptin hydrochloride) — AstraZeneca AB
EMA authorised Komboglyze, a fixed-dose combination of metformin hydrochloride and saxagliptin hydrochloride for type 2 diabetes mellitus, m…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) [Phase 1]
Phase 1 pharmacokinetics and bioequivalence study comparing Gedeon Richter’s empagliflozin/metformin hydrochloride 12.5 mg/1000 mg film-coat…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting [Phase 1]
Phase 1 study to characterize how a new long-acting insulin behaves in the body during exercise and prolonged fasting in adults with Type 2 …
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes [NA]
This ClinicalTrials.gov update reports the results of a study examining whether consuming whole fruit improves glycemic control in adults wi…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation [NA]
This document reports the completion of a clinical investigation evaluating Actiste Diabetes Management as a Service (ADMS) for individuals …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users
This trial evaluates gastric emptying in healthy volunteers and GLP-1 receptor agonist users. Recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes. [NA]
A clinical trial is evaluating dietetics support with and without continuous glucose monitoring in adults with Type 2 Diabetes, currently re…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Exploration of the Perceptions of Women With a History of Gestational Diabetes From the Gonesse Hospital Catchment Area Regarding Their Risk of Developing Type 2 Diabetes.
Clinical trial update about how women with a history of gestational diabetes perceive their risk of developing type 2 diabetes, based on a c…